Axsome Therapeutics Inc. (AXSM)
Axsome Therapeutics Statistics
Share Statistics
Axsome Therapeutics has 49.24M shares outstanding. The number of shares has increased by 2.67% in one year.
| 49.24M |
| 2.67% |
| 0.63% |
| 77.28% |
| n/a |
| 300 |
| 0.04% |
Short Selling Information
The latest short interest is 3.89M, so 7.97% of the outstanding shares have been sold short.
| 3.89M |
| 7.97% |
| 9.53% |
| 5.64 |
Valuation Ratios
The PE ratio is -14.11 and the forward PE ratio is 62.57. Axsome Therapeutics's PEG ratio is -1.03.
| -14.11 |
| 62.57 |
| 10.51 |
| 2 |
| 71.1 |
| -31.5 |
| -1.03 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for Axsome Therapeutics.
| n/a |
| n/a |
| n/a |
| n/a |
Financial Position
The company has a current ratio of 2.11, with a Debt / Equity ratio of 3.38.
| 2.11 |
| 2.04 |
| 3.38 |
| -0.71 |
| -1.5 |
| -42.71 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| n/a |
| n/a |
| n/a |
| $541,703.65 |
| $-403,393.26 |
| 712 |
| 0.68 |
| 2.12 |
Taxes
| 85K |
| -0.03% |
Stock Price Statistics
The stock price has increased by 48.18% in the last 52 weeks. The beta is 0.47, so Axsome Therapeutics's price volatility has been higher than the market average.
| 0.47 |
| 48.18% |
| 107.28 |
| 101.68 |
| 56.54 |
| 702,607 |
Income Statement
In the last 12 months, Axsome Therapeutics had revenue of 385.69M and earned -287.22M in profits. Earnings per share was -5.99.
| 385.69M |
| 352.39M |
| -280.56M |
| -287.22M |
| -272.6M |
| -280.56M |
| -5.99 |
Balance Sheet
The company has 315.35M in cash and 192.96M in debt, giving a net cash position of 122.4M.
| 315.35M |
| 192.96M |
| 122.4M |
| -1.12B |
| 596.67M |
| 250.72M |
Cash Flow
In the last 12 months, operating cash flow was -128.41M and capital expenditures -270K, giving a free cash flow of -128.68M.
| -128.41M |
| -270K |
| -128.68M |
| -2.69 |
Margins
Gross margin is 91.37%, with operating and profit margins of -72.74% and -74.47%.
| 91.37% |
| -72.74% |
| -74.45% |
| -74.47% |
| -70.68% |
| -72.74% |
| -33.36% |
Dividends & Yields
AXSM does not appear to pay any dividends at this time.
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
| n/a |
Analyst Forecast
The average price target for AXSM is $178, which is 60.7% higher than the current price. The consensus rating is "Buy".
| $178 |
| 60.7% |
| Buy |
| 15 |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| n/a |
| n/a |
| n/a |
| n/a |
Scores
| 2.52 |
| 3 |